(Q43276874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Sylvie Mesrine

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Marie-Christine Boutron-Ruault

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Françoise Clavel-Chapelon

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

14 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

5138-5143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

7 February 2020

cites work

1 reference

12 December 2020

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

12 December 2020

Hormone replacement therapy in relation to breast cancer

1 reference

12 December 2020

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses

1 reference

12 December 2020

Postmenopausal estrogen and progestin use in relation to breast cancer risk

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

1 reference

12 December 2020

Hormone replacement therapy regimens and breast cancer risk(1).

1 reference

12 December 2020

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

1 reference

12 December 2020

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

12 December 2020

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

1 reference

12 December 2020

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

12 December 2020

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

1 reference

12 December 2020

Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis

1 reference

12 December 2020

Breast cancer risk with postmenopausal hormonal treatment

1 reference

12 December 2020

Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort

1 reference

12 December 2020

1 reference

12 December 2020

Body size, hormone therapy and risk of breast cancer in Asian-American women

1 reference

12 December 2020

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

1 reference

12 December 2020

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

1 reference

12 December 2020

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

1 reference

12 December 2020

Hormones and heart disease in women: the timing hypothesis

1 reference

12 December 2020

Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study .

1 reference

12 December 2020

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

1 reference

12 December 2020

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women

1 reference

12 December 2020

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study

1 reference

12 December 2020

The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

1 reference

12 December 2020

Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis

1 reference

12 December 2020

Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort

1 reference

12 December 2020

Hormone replacement therapy

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.21.6432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19752341%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference